These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2977929)

  • 1. Some characteristics of chemically-induced beta-cell lesions as possible contributing factors in diabetes.
    Grodsky GM; Bolaffi JL
    Adv Exp Med Biol; 1988; 246():339-46. PubMed ID: 2977929
    [No Abstract]   [Full Text] [Related]  

  • 2. Ex vivo gene transfer of viral interleukin-10 to BB rat islets: no protection after transplantation to diabetic BB rats.
    Kuttler B; Wanka H; Klöting N; Gerstmayer B; Volk HD; Sawitzki B; Ritter T
    J Cell Mol Med; 2007; 11(4):868-80. PubMed ID: 17760846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholecystokinin octapeptide: a potential growth factor for pancreatic beta cells in diabetic rats.
    Kuntz E; Pinget M; Damgé P
    JOP; 2004 Nov; 5(6):464-75. PubMed ID: 15536283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose cycling in islets from healthy and diabetic rats.
    Khan A; Chandramouli V; Ostenson CG; Löw H; Landau BR; Efendić S
    Diabetes; 1990 Apr; 39(4):456-9. PubMed ID: 2180757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose and alloxan interactions in the pancreatic islets.
    Zawalich WS; Beidler LM
    Am J Physiol; 1973 Apr; 224(4):963-6. PubMed ID: 4266918
    [No Abstract]   [Full Text] [Related]  

  • 6. Protection by thymidine, an inhibitor of polyadenosine diphosphate ribosylation, of streptozotocin inhibition of insulin secretion.
    Bolaffi JL; Nagamatsu S; Harris J; Grodsky GM
    Endocrinology; 1987 May; 120(5):2117-22. PubMed ID: 2952491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Previous adaptation to a high-protein diet protects against streptozotocin-induced inhibition of insulin release from isolated rat islets.
    Eizirik DL; Boschero AC; Migliorini RH
    Braz J Med Biol Res; 1985; 18(2):233-5. PubMed ID: 2937500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-cell function and islet morphology in normal, obese, and obese beta-cell mass-reduced Göttingen minipigs.
    Larsen MO; Juhl CB; Pørksen N; Gotfredsen CF; Carr RD; Ribel U; Wilken M; Rolin B
    Am J Physiol Endocrinol Metab; 2005 Feb; 288(2):E412-21. PubMed ID: 15479954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclosporine potentiates the in vivo effect of streptozotocin in impairing rat pancreas insulin content.
    Gaja S; Marni A; Ferrero ME
    Transplant Proc; 1990 Oct; 22(5):2250-2. PubMed ID: 2145675
    [No Abstract]   [Full Text] [Related]  

  • 10. Sensitivity of porcine islet beta cells to the diabetogenic action of streptozotocin.
    Liu X; Mellert J; Hering BJ; Brendel MD; Federlin K; Bretzel RG; Hopt UT
    Transplant Proc; 1998 Mar; 30(2):574-5. PubMed ID: 9532181
    [No Abstract]   [Full Text] [Related]  

  • 11. Sensitivity of BB rat beta cells as determined by dose-responses to the cytotoxic effects of streptozotocin and alloxan.
    Yale JF; Grose M; Videtic GM; Marliss EB
    Diabetes Res; 1986 Mar; 3(3):161-7. PubMed ID: 2940045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced expression of the liver/beta-cell glucose transporter isoform in glucose-insensitive pancreatic beta cells of diabetic rats.
    Thorens B; Weir GC; Leahy JL; Lodish HF; Bonner-Weir S
    Proc Natl Acad Sci U S A; 1990 Sep; 87(17):6492-6. PubMed ID: 2204056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concanavalin A and alloxan interactions on glucose-induced insulin secretion and biosynthesis from islets of Langerhans.
    Virji MA; Steffes MW; Estensen RD
    Diabetes; 1984 Feb; 33(2):164-9. PubMed ID: 6363170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recovery of glucose-induced insulin secretion in a rat model of NIDDM is not accompanied by return of the B-cell GLUT2 glucose transporter.
    Chen C; Thorens B; Bonner-Weir S; Weir GC; Leahy JL
    Diabetes; 1992 Oct; 41(10):1320-7. PubMed ID: 1397706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modifications of the endocrine pancreas in rats after mixed endocrine-exocrine destruction by streptozotocin and ethionine with a protein-free diet.
    Michel C; Chariot J; Souchard M; Rozé C
    Cell Mol Biol; 1986; 32(1):41-54. PubMed ID: 2936454
    [No Abstract]   [Full Text] [Related]  

  • 16. Metabolic and histopathological effects of streptozotocin induced diabetes in rats: effect of propranolol and insulin.
    Bora PS; Srivastava LM; Bhatt SD
    Indian J Exp Biol; 1985 Jan; 23(1):23-6. PubMed ID: 3160657
    [No Abstract]   [Full Text] [Related]  

  • 17. A novel dipeptidyl peptidase IV inhibitor DA-1229 ameliorates streptozotocin-induced diabetes by increasing β-cell replication and neogenesis.
    Cho JM; Jang HW; Cheon H; Jeong YT; Kim DH; Lim YM; Choi SH; Yang EK; Shin CY; Son MH; Kim SH; Kim HJ; Lee MS
    Diabetes Res Clin Pract; 2011 Jan; 91(1):72-9. PubMed ID: 21093089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Monolayer culture of pancreatic beta cells of newborn rats: Insulin secretion in vitro and attempt at beta-cell transplantation in experimental diabetes].
    Fedotov VP; Komolov IS; Sadovnikova NV; Maslennikova VG
    Probl Endokrinol (Mosk); 1978; 24(4):57-60. PubMed ID: 150594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of poly (ADP-ribose) synthetase by gene disruption or inhibition with 5-iodo-6-amino-1,2-benzopyrone protects mice from multiple-low-dose-streptozotocin-induced diabetes.
    Mabley JG; Suarez-Pinzon WL; Haskó G; Salzman AL; Rabinovitch A; Kun E; Szabó C
    Br J Pharmacol; 2001 Jul; 133(6):909-19. PubMed ID: 11454665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Investigation of diabetogenic action of xanthurenic acid].
    Meíramov GG; Andreeva AP; Konert KD
    Biull Eksp Biol Med; 1997 Jun; 123(6):669-72. PubMed ID: 9280523
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.